Immgolis: First Interchangeable Biosimilar to Simponi
Analyze the FDA approval of Immgolis (golimumab-sldi), the first interchangeable Simponi biosimilar. Learn how auto-substitution impacts rheumatology care.
Back to Articles
Articles tagged with “rheumatology”